CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,429,000 | -31.1% | 85,738 | -67.0% | 0.01% | -28.6% |
| Q2 2022 | $6,431,000 | +3.8% | 259,519 | +5.0% | 0.01% | +16.7% |
| Q1 2022 | $6,197,000 | -34.3% | 247,172 | -4.6% | 0.01% | -33.3% |
| Q4 2021 | $9,434,000 | +44.5% | 259,097 | -32.1% | 0.02% | +38.5% |
| Q3 2021 | $6,530,000 | +54.0% | 381,860 | +20.6% | 0.01% | +44.4% |
| Q2 2021 | $4,241,000 | -64.7% | 316,702 | +34.9% | 0.01% | -66.7% |
| Q1 2021 | $12,031,000 | -2.9% | 234,799 | +17.3% | 0.03% | -12.9% |
| Q4 2020 | $12,391,000 | +294.6% | 200,105 | +249.3% | 0.03% | +244.4% |
| Q3 2020 | $3,140,000 | -12.9% | 57,293 | -8.6% | 0.01% | -18.2% |
| Q2 2020 | $3,607,000 | +133.5% | 62,680 | +63.0% | 0.01% | +57.1% |
| Q1 2020 | $1,545,000 | +461.8% | 38,448 | +453.2% | 0.01% | +600.0% |
| Q4 2019 | $275,000 | – | 6,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |